NPT
RNXT icon

Nixon Peabody Trust’s RenovoRx RNXT Stock Holding History

Nixon Peabody Trust’s Portfolio RNXT Stock Details RNXT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-97,165
Closed -$98.1K – 183
2026
Q1 		$98.1K Hold
97,165
– – 0.01% 159
2025
Q4 		$81.6K Hold
97,165
– – 0.01% 159
2025
Q3 		$123K Hold
97,165
– – 0.01% 151
2025
Q2 		$128K Hold
97,165
– – 0.01% 147
2025
Q1 		$96.2K Hold
97,165
– – 0.01% 151
2024
Q4 		$125K Hold
97,165
– – 0.01% 145
2024
Q3 		$103K Hold
97,165
– – 0.01% 137
2024
Q2 		$110K Hold
97,165
– – 0.01% 127
2024
Q1 		$130K Hold
97,165
– – 0.01% 125
2023
Q4 		$223K Buy
+97,165
New +$92.6K 0.03% 124

Other funds holding RNXT

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $18.2B AUM 21.48% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $187B AUM 21.7% 1-Year Est. Return

Nixon Peabody Trust's RNXT Position: Q2 2026 in Review

Nixon Peabody Trust sold out of RenovoRx (RNXT) in Q2 2026, closing a stake of 97,165 shares — an estimated $98.1K sold.

Nixon Peabody Trust first reported a position in RNXT in Q4 2023 and held it in 10 quarters. The position peaked at $223K in Q4 2023. 28 funds tracked by Wall St. Rank hold RNXT as of Q2 2026.

  • Nixon Peabody Trust reported no remaining RenovoRx position as of Q2 2026 after selling out during the quarter.
  • Nixon Peabody Trust sold 97,165 RenovoRx shares in Q2 2026, an estimated $98.1K.
  • Nixon Peabody Trust first reported a position in RenovoRx in Q4 2023 and held it in 10 quarters.
  • Nixon Peabody Trust's RenovoRx position peaked at $223K in Q4 2023.
  • 28 funds tracked by Wall St. Rank held RenovoRx as of Q2 2026.

Based on Nixon Peabody Trust's 13F filing for Q2 2026, filed 27 Jul 2026.